Does IXEKIZUMAB Cause Injection site swelling? 1,615 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,615 reports of Injection site swelling have been filed in association with IXEKIZUMAB (TALTZ). This represents 4.8% of all adverse event reports for IXEKIZUMAB.
1,615
Reports of Injection site swelling with IXEKIZUMAB
4.8%
of all IXEKIZUMAB reports
1
Deaths
27
Hospitalizations
How Dangerous Is Injection site swelling From IXEKIZUMAB?
Of the 1,615 reports, 1 (0.1%) resulted in death, 27 (1.7%) required hospitalization, and 2 (0.1%) were considered life-threatening.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 1,615 reports have been filed with the FAERS database.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
Injection site pruritus (772)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
CERTOLIZUMAB PEGOL (782)
Which IXEKIZUMAB Alternatives Have Lower Injection site swelling Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID